Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), explore reasons for switching and to compare results to previously published data. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhushan, Vandana, Lester, Susan, Briggs, Liz, Hijjawi, Raif, Shanahan, E. Michael, Pontifex, Eliza, Ninan, Jem, Hill, Catherine, Cai, Fin, Walker, Jennifer, Goldblatt, Fiona, Wechalekar, Mihir D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502861/
https://www.ncbi.nlm.nih.gov/pubmed/34646840
http://dx.doi.org/10.3389/fmed.2021.708168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502861/
https://www.ncbi.nlm.nih.gov/pubmed/34646840
http://dx.doi.org/10.3389/fmed.2021.708168

Ejemplares similares